| | | | | |
RNAC Cartesian Therapeutics, Inc. Common Stock | €8,5378 | -2,40 % | €272,46M | €32,83K | |
FUND Sprott Focus Trust, Inc. | €9,2632 | +0,19 % | €272,31M | €11,18K | |
FATE Fate Therapeutics, Inc. | €2,1763 | -1,36 % | €272,17M | €387,54K | |
NMRA Neumora Therapeutics, Inc. Common Stock | €1,2920 | -3,53 % | €272,00M | €327,23K | |
GALT Galectin Therapeutics Inc. | €3,5465 | -0,46 % | €271,85M | €237,46K | |
NREF NexPoint Real Estate Finance, Inc. | €14,9061 | +1,01 % | €271,84M | €23,86K | |
POLE Andretti Acquisition Corp. II Class A Ordinary Shares | €9,2933 | +0,51 % | €271,58M | €16,31 | |
PSBD Palmer Square Capital BDC Inc. | €8,7790 | -0,72 % | €271,56M | €18,08K | |
| €2,6914 | -3,24 % | €271,36M | €341,01K | |
| €5,5931 | -1,14 % | €271,18M | €4,24K | |
SMTI Sanara MedTech Inc. Common Stock | €29,7299 | -0,06 % | €270,94M | €99,72K | |
MLP Maui Land & Pineapple Co. | €13,5128 | -1,56 % | €270,90M | €4,01K | |
AFB Alliance National Municipal Income Fund, Inc. | €9,3671 | -0,04 % | €270,71M | €34,78K | |
| €36,8065 | +0,36 % | €270,68M | €8,76K | |
TVA Texas Ventures Acquisition III Corp Class A Ordinary Share | €9,0529 | +0,00 % | €270,68M | €42,99K | |
